Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is at least 18 years of age~* Level of severity of bilateral nasolabial fold wrinkles meeting severity criteria as per protocol~* Level of subject dissatisfaction with both nasolabial fold wrinkles as per protocol~* Ability to comply with the study requirements~* Negative pregnancy test (Females)~* Healthy post-auricular skin for biopsy~Exclusion Criteria:~* Excessive dermatochalasis of the treatment area~* Inability to lessen the nasolabial fold wrinkles by physically spreading the area apart~* Total area to be treated exceeds 20 cm in length~* Physical attributes which may prevent assessment or treatment as judged by the evaluator~* Use of an investigational product/procedure within 30 days prior to enrollment or plans for use during the study~* Previous treatment with the sponsor's product~* History of active autoimmune disease or organ transplantation~* Diagnosis of cancer, unless successfully treated or in remission (basal cell carcinoma is excluded)~* Active or chronic skin disease~* Known genetic disorders affecting fibroblasts or collagen~* Active systemic infection~* Requires chronic antibiotic or steroidal therapy~* Use of certain commercial products/procedures to the treatment area prior to study enrollment or plans for use during the study~* Use of systemic agents that increase bleeding or clotting, or disorders equated with these effects~* Known allergic reactions to agents used in preparation of treatment~* Excessive exposure to sun without adequate sun protection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).